Loading...
Loading...
Among the 3 tracked institutional investors we monitor, TCRT (ALAUNOS THERAPEUTICS INC) is held with a combined value of $188.25K across 61,933 shares. The largest holder is VANGUARD GROUP INC with a position worth $97.10K (0.00% of their portfolio). 2 funds opened new positions in the most recent quarter. 1 fund reduced its position.
Total Institutional Value
$188.25K
Total Shares Held
61,933
Institutional Holders
3
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $97.10K | 0.00% | New |
| 2 | BlackRock, Inc. | $61.07K | 0.00% | - |
| 3 | CITADEL ADVISORS LLC | $30.08K | 0.00% | New |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of TCRT with a position worth $97.10K, representing 0.00% of their portfolio. In total, 3 institutional investors hold TCRT with a combined value of $188.25K.
In the most recent quarter, 2 funds opened a new position in TCRT. Additionally, 1 reduced their positions.
Institutional investors hold $188.25K worth of TCRT stock across 3 positions. The largest institutional holder is VANGUARD GROUP INC with $97.10K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For TCRT, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their TCRT positions.